RRC ID 61035
著者 Fujimura S, Suzumiya J, Nakamura K, Ono J.
タイトル Effects of troglitazone on the growth and differentiation of hematopoietic cell lines.
ジャーナル Int J Oncol
Abstract Troglitazone (Tro), one of the thiazolidinediones, is a novel antidiabetic agent for patients with type 2 diabetes mellitus. Tro is a specific ligand of PPARgamma, the nuclear receptor that regulates the growth and differentiation of cells at the transcriptional level. We attempted to investigate the effect of Tro on HL-60 and other hematopoietic cell lines and thus found HL-60 cells to be arrested at the G1 phase and to differentiate into monocytes. In addition, apoptosis was also induced by Tro at higher concentrations. The G1 arrest was induced in all the hematopoietic cell lines examined while differentiation into the monocytic lineage was observed not only in the myelogenous and promonocytic cell lines but also in an erythroleukemia cell line.
巻・号 13(6)
ページ 1263-7
公開日 1998-12-1
DOI 10.3892/ijo.13.6.1263
PMID 9824642
MeSH Animals Cell Cycle / drug effects Cell Cycle Proteins / metabolism Cell Differentiation / drug effects Cell Division / drug effects Cell Line Chromans / pharmacology* G1 Phase / drug effects HL-60 Cells Hematopoietic Stem Cells / cytology Hematopoietic Stem Cells / drug effects* Humans Hypoglycemic Agents / pharmacology* Mice Monocytes / cytology Monocytes / metabolism Phosphorylation Retinoblastoma Protein / metabolism Thiazoles / pharmacology* Thiazolidinediones* Troglitazone Vitamin E / pharmacology
IF 3.899
オルトメトリクス指標
オルトメトリクス指標項目
最多言及媒体 Patent(IFI CLAIMS)
各媒体での言及数の合計 3
過去6か月間でのオルトメトリクス指標の変動値 0.0
リソース情報
ヒト・動物細胞 HL60(RCB0041)